Biblioteca Humberto Rosselli Quijano
Información del autor
Autor Jessica A. Johnson |
Documentos disponibles escritos por este autor (1)
Refinar búsqueda
Efficacy of intravenous ketamine in adolescent treatment-resistant depression / Jennifer B. Dwyer en The American Journal of Psychiatry, Año 2021 - Vol. 178 - No.4 (Abril)
[artículo]
Título : Efficacy of intravenous ketamine in adolescent treatment-resistant depression : a randomized midazolam-controlled trial Tipo de documento: texto impreso Autores: Jennifer B. Dwyer, Autor ; Angeli Landeros Weisenberger, Autor ; Jessica A. Johnson, Autor Fecha de publicación: 2021 Artículo en la página: pp. 352-362 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Trastornos depresivos, Trastorno depresivo mayor, Psiquiatría de niños y adolescentes, Ketamina, Esketamina Resumen: Adolescent depression is prevalent and is associated with significant morbidity and mortality. Although intravenous ketamine has shown efficacy in adult treatment-resistant depression, its efficacy in pediatric populations is unknown. The authors conducted an active-placebo-controlled study of ketamine’s safety and efficacy in adolescents. Link: ./index.php?lvl=notice_display&id=26888
in The American Journal of Psychiatry > Año 2021 - Vol. 178 - No.4 (Abril) . - pp. 352-362[artículo] Efficacy of intravenous ketamine in adolescent treatment-resistant depression : a randomized midazolam-controlled trial [texto impreso] / Jennifer B. Dwyer, Autor ; Angeli Landeros Weisenberger, Autor ; Jessica A. Johnson, Autor . - 2021 . - pp. 352-362.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in The American Journal of Psychiatry > Año 2021 - Vol. 178 - No.4 (Abril) . - pp. 352-362
Palabras clave: Trastornos depresivos, Trastorno depresivo mayor, Psiquiatría de niños y adolescentes, Ketamina, Esketamina Resumen: Adolescent depression is prevalent and is associated with significant morbidity and mortality. Although intravenous ketamine has shown efficacy in adult treatment-resistant depression, its efficacy in pediatric populations is unknown. The authors conducted an active-placebo-controlled study of ketamine’s safety and efficacy in adolescents. Link: ./index.php?lvl=notice_display&id=26888